BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1530589)

  • 1. Increased intestinal protein synthesis during sepsis and following the administration of tumour necrosis factor alpha or interleukin-1 alpha.
    von Allmen D; Hasselgren PO; Higashiguchi T; Frederick J; Zamir O; Fischer JE
    Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):585-9. PubMed ID: 1530589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis in rats stimulates cellular proliferation in the mucosa of the small intestine.
    Rafferty JF; Noguchi Y; Fischer JE; Hasselgren PO
    Gastroenterology; 1994 Jul; 107(1):121-7. PubMed ID: 8020655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of human recombinant tumor necrosis factor-alpha and interleukin 1 on the synthesis of glycosaminoglycan and DNA in cultured rat costal chondrocytes.
    Ikebe T; Hirata M; Koga T
    J Immunol; 1988 Feb; 140(3):827-31. PubMed ID: 3257505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endotoxemia and IL-1 beta stimulate mucosal IL-6 production in different parts of the gastrointestinal tract.
    Wang Q; Wang JJ; Boyce S; Fischer JE; Hasselgren PO
    J Surg Res; 1998 Apr; 76(1):27-31. PubMed ID: 9695734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sepsis on mucosal protein synthesis in different parts of the gastrointestinal tract in rats.
    Higashiguchi T; Noguchi Y; O'Brien W; Wagner K; Fischer JE; Hasselgren PO
    Clin Sci (Lond); 1994 Aug; 87(2):207-11. PubMed ID: 7924166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of unfractionated heparin on the expression of heme oxygenase-1 in intestinal mucosa of mice with sepsis].
    Yin X; Chen S; Hu Z; Xiao F; Lu S; Ma X; Luan Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 May; 28(5):423-6. PubMed ID: 29920038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor and interleukin-1 protection against the lethal effects of tumor necrosis factor.
    Sheppard BC; Norton JA
    Surgery; 1991 Jun; 109(6):698-705. PubMed ID: 2042087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Shenfu injection on intestinal mucosal barrier in a rat model of sepsis.
    Wu W; Jiang RL; Wang LC; Lei S; Xing X; Zhi YH; Wu JN; Wu YC; Zhu MF; Huang LQ
    Am J Emerg Med; 2015 Sep; 33(9):1237-43. PubMed ID: 26099787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced muscle protein breakdown in septic rats following treatment with interleukin-1 receptor antagonist.
    Zamir O; O'Brien W; Thompson R; Bloedow DC; Fischer JE; Hasselgren PO
    Int J Biochem; 1994 Jul; 26(7):943-50. PubMed ID: 8063018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity.
    Mandrup-Poulsen T; Bendtzen K; Dinarello CA; Nerup J
    J Immunol; 1987 Dec; 139(12):4077-82. PubMed ID: 3320203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sepsis or cytokine administration on release of gut peptides.
    Zamir O; Hasselgren PO; Higashiguchi T; Frederick JA; Fischer JE
    Am J Surg; 1992 Jan; 163(1):181-4; discussion 184-5. PubMed ID: 1733367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of recombinant IL-1 and recombinant tumor necrosis factor in the induction of mouse acute phase proteins.
    Mortensen RF; Shapiro J; Lin BF; Douches S; Neta R
    J Immunol; 1988 Apr; 140(7):2260-6. PubMed ID: 2450915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis.
    Alexander HR; Sheppard BC; Jensen JC; Langstein HN; Buresh CM; Venzon D; Walker EC; Fraker DL; Stovroff MC; Norton JA
    J Clin Invest; 1991 Jul; 88(1):34-9. PubMed ID: 2056127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1.
    Jelinek DF; Lipsky PE
    J Immunol; 1987 Nov; 139(9):2970-6. PubMed ID: 3117883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis.
    Zamir O; Hasselgren PO; Kunkel SL; Frederick J; Higashiguchi T; Fischer JE
    Arch Surg; 1992 Feb; 127(2):170-4. PubMed ID: 1540094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin upregulates PepT1 activity in the small intestine epithelium of rats with sepsis.
    Liu J; Shi B; Shi K; Ma G; Zhang H; Lou X; Liu H; Wan S; Liang D
    Biomed Pharmacother; 2017 Feb; 86():669-676. PubMed ID: 28038428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shenfu injection alleviates intestine epithelial damage in septic rats.
    Xing X; Jiang R; Wang L; Lei S; Zhi Y; Wu Y; Zhu M; Huang L; Xia G; Chen Z
    Am J Emerg Med; 2015 Nov; 33(11):1665-70. PubMed ID: 26324011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a circulating proteolysis-inducing factor during sepsis?
    Hasselgren PO; James JH; Benson DW; Li S; Fischer JE
    Arch Surg; 1990 Apr; 125(4):510-4. PubMed ID: 2322118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 induced impairment in pancreatic islet oxidative metabolism of glucose is potentiated by tumor necrosis factor.
    Eizirik DL
    Acta Endocrinol (Copenh); 1988 Nov; 119(3):321-5. PubMed ID: 3055785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intracerebroventricular injection of tumor necrosis factor alpha on gut mucosal protein turnover in mice fed enterally.
    Yoshida S; Yoshizumi T; Kamei H; Ozaki K; Yahara T; Tajiri T; Yamasaki K; Shirouzu K
    J Surg Res; 1999 Nov; 87(1):73-6. PubMed ID: 10527706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.